Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: Importance of cyclic GMP

Cardiovascular Research

Volumn 57, Issue 2, 2003, Pages 515-522

  Rosenkranz, Anke C ^a   Woods, Robyn L ^a   Dusting, Gregory J ^a   Ritchie, Rebecca H ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Angiotensin; Hypertrophy; Natriuretic peptide; Second messengers

Indexed keywords

8 BROMO CYCLIC GMP; ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; BIOCHEMICAL MARKER; CYCLIC GMP; GUANYLATE CYCLASE; GUANYLATE CYCLASE RECEPTOR; HS 142 1; KT 5823; MESSENGER RNA; NATRIURETIC PEPTIDE TYPE A; NATRIURETIC PEPTIDE TYPE B; NATRIURETIC PEPTIDE TYPE C; PHENYLALANINE; PROTEIN C FOS; RECEPTOR; TRITIUM; UNCLASSIFIED DRUG;

AGE; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM; ENZYME ACTIVATION; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART PROTECTION; IN VITRO STUDY; INCUBATION TIME; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANGIOTENSIN II; ANIMALS; ATRIAL NATRIURETIC FACTOR; CARDIOMEGALY; CYCLIC GMP; DRUG INTERACTIONS; GUANYLATE CYCLASE; MALE; MUSCLE CELLS; NATRIURETIC PEPTIDE, BRAIN; NATRIURETIC PEPTIDE, C-TYPE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ATRIAL NATRIURETIC FACTOR;

EID: 0037306002     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(02)00667-3     Document Type: Article

References (49)

1. Morgan H., Gordon E., Kira Y., et al. Biochemical mechanisms of cardiac hypertrophy. Annu. Rev. Physiol. 49:1987;533-543.
2. Dunn F.G., McLenachan J., Isles C.G., et al. Left ventricular hypertrophy and mortality in hypertension: an analysis of data from the Glasgow Blood Pressure Clinic. J. Hypertens. 8:1990;775-782.
3. Sugden P.H., Clerk A. Cellular mechanisms of cardiac hypertrophy. J. Mol. Med. 76:1998;725-746.
4. Calderone A., Thaik C.M., Takahashi N., Chang D.L.F., Colucci W.S. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts. J. Clin. Invest. 101:1998;812-818.
5. Horio T., Nishikimi T., Yoshihara F., Matsuo H., Takishita S., Kangawa K. Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes. Hypertension. 35:2000;19-24.
6. Chen H.H., Burnett J.C. Natriuretic peptides in the pathophysiology of congestive heart failure. Curr. Cardiol. Rep. 2:2000;198-205.
7. Forssmann W.-G., Richter R., Meyer M. The endocrine heart and natriuretic peptides: histochemistry, cell biology, and functional aspects of the renal urodilatin system. Histochem. Cell Biol. 110:1998;335-357.
8. Chen H.H., Burnett J.C. Jr. C-type natriuretic peptide: the endothelial component of the natriuretic peptide system. J. Cardiovasc. Pharmacol. 32:1998;S22-S28.
9. Nunez D.J., Dickson M.C., Brown M.J. Natriuretic peptide receptor mRNAs in the rat and human heart. J. Clin. Invest. 90:1992;1966-1971.
10. John S.W., Krege J.H., Oliver P.M., et al. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science. 267:1995;679-681.
11. Klinger J.R., Warburton R.R., Pietras L.A., Smithies O., Swift R., Hill N.S. Genetic disruption of atrial natriuretic peptide causes pulmonary hypertension in normoxic and hypoxic mice. Am. J. Physiol. 276:1999;L868-L874.
12. Oliver P.M., Fox J.E., Kim R., et al. Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc. Natl. Acad. Sci. U.S.A. 94:1997;14730-14735.
13. Tamura N., Ogawa Y., Chusho H., et al. Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc. Natl. Acad. Sci. U.S.A. 97:2000;4239-4244.
14. Ogawa Y., Tamura N., Chusho H., Nakao K. Brain natriuretic peptide appears to act locally as an antifibrotic factor in the heart. Can. J. Physiol. Pharmacol. 79:2001;723-729.
15. Arjona A.A., Hsu C.A., Wrenn D.S., Hill N.S. Effects of natriuretic peptides on vascular smooth-muscle cells derived from different vascular beds. Gen. Pharmacol. 28:1997;387-392.
16. Kumar R., Joyner R.W., Komalavilas P., Lincoln T.M. Analysis of expression of cGMP-dependent protein kinase in rabbit heart cells. J. Pharmacol. Exp. Ther. 291:1999;967-975.
17. Rosenkranz A.C., Dusting G.J., Ritchie R.H. Endothelial dysfunction limits the antihypertrophic action of bradykinin in rat cardiomyocytes. J. Mol. Cell. Cardiol. 32:2000;1119-1126.
18. Morishita Y., Sano T., Ando K., Saitoh Y., Kase H., Yamada K., Matsuda Y. Microbial polysaccharide, HS-142-1, competitively and selectively inhibits ANP binding to its guanylyl cyclase-containing receptor. Biochem. Biophys. Res. Commun. 176:1991;949-957.
19. Grider J.R. Interplay of VIP and nitric oxide in regulation of the descending relaxation phase of peristalsis. Am. J. Physiol. 264:1993;G334-G340.
20. Sadoshima J., Izumo S. Molecular characterization of angiotensin II - induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ. Res. 73:1993;413-423.
21. Izumo S., Nadal-Ginard B., Mahdavi V. Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc. Natl. Acad. Sci. U.S.A. 85:1988;339-343.
22. Heid C.A., Stevens J., Livak K.J., Williams P.M. Real time quantitative PCR. Genome Res. 6:1996;986-994.
23. Winer J., Jung C.K., Shackel I., Williams P.M. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal. Biochem. 270:1999;41-49.
24. Brunner F., Wolkart G. Endothelial NO/cGMP system contributes to natriuretic peptide-mediated coronary and peripheral vasodilation. Microvasc. Res. 61:2001;102-110.
25. Kishimoto I., Rossi K., Garbers D.L. A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy. Proc. Natl. Acad. Sci. U.S.A. 98:2001;2703-2706.
26. Johnston C.I., Hodsman G.P., Harrison R.W., Mendelsohn F.A., Tsunoda K. Regulation of cardiac preload by atrial natriuretic peptide in congestive cardiac failure. Am. J. Med. 84:1988;105-111.
27. Tsutamoto T., Kanamori T., Morigami N., Sugimoto Y., Yamaoka O., Kinoshita M. Possibility of downregulation of atrial natriuretic peptide receptor coupled to guanylate cyclase in peripheral vascular beds of patients with chronic severe heart failure. Circulation. 87:1993;70-75.
28. Wilkins M.R., Redondo J., Brown L.A. The natriuretic-peptide family. Lancet. 349:1997;1307-1310.
29. Ritchie R.H., Schiebinger R.J., LaPointe M.C., Marsh J.D. Angiotensin II-induced hypertrophy of adult rat cardiomyocytes is blocked by nitric oxide. Am. J. Physiol. 275:1998;H1370-1374.
30. Butt E., Geiger J., Jarchau T., Lohmann S.M., Walter U. The cGMP-dependent protein kinase - gene, protein, and function. Neurochem. Res. 18:1993;27-42.
31. Hofmann F., Ammendola A., Schlossmann J. Rising behind NO: cGMP-dependent protein kinases. J. Cell Sci. 113:2000;1671-1676.
32. Pandey K.N., Nguyen H.T., Li M., Boyle J.W. Natriuretic peptide receptor-A negatively regulates mitogen-activated protein kinase and proliferation of mesangial cells: role of cGMP-dependent protein kinase. Biochem. Biophys. Res. Commun. 271:2000;374-379.
33. Wollert K.C., Fiedler B., Gambaryan S., et al. Gene transfer of cGMP-dependent protein kinase I enhances the antihypertrophic effects of nitric oxide in cardiomyocytes. Hypertension. 39:2002;87-92.
34. Suhasini M., Li H., Lohmann S.M., Boss G.R., Pilz R.B. Cyclic-GMP-dependent protein kinase inhibits the Ras/Mitogen-activated protein kinase pathway. Mol. Cell. Biol. 18:1998;6983-6994.
35. Yu S.M., Hung L.M., Lin C.C. cGMP-elevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epidermal growth factor signaling pathway. Circulation. 95:1997;1269-1277.
36. Silberbach M., Gorenc T., Hershberger R.E., Stork P.J., Steyger P.S., Roberts C.T. Jr. Extracellular signal-regulated protein kinase activation is required for the anti-hypertrophic effect of atrial natriuretic factor in neonatal rat ventricular myocytes. J. Biol. Chem. 274:1999;24858-24864.
37. Lin X., Hanze J., Heese F., Sodmann R., Lang R.E. Gene expression of natriuretic peptide receptors in myocardial cells. Circ. Res. 77:1995;750-758.
38. Koller K.J., Goeddel D.V. Molecular biology of the natriuretic peptides and their receptors. Circulation. 86:1992;1081-1088.
39. Sugimoto T., Haneda M., Togawa M., et al. Atrial natriuretic peptide induces the expression of MKP-1, a mitogen-activated protein kinase phosphatase, in glomerular mesangial cells. J. Biol. Chem. 271:1996;544-547.
40. Prins B.A., Weber M.J., Hu R.M., Pedram A., Daniels M., Levin E.R. Atrial natriuretic peptide inhibits mitogen-activated protein kinase through the clearance receptor. Potential role in the inhibition of astrocyte proliferation. J. Biol. Chem. 271:1996;14156-14162.
41. Mohammadi K., Rouet-Benzineb P., Laplace M., Crozatier B. Protein kinase C activity and expression in rabbit left ventricular hypertrophy. J. Mol. Cell Cardiol. 29:1997;1687-1694.
42. Kim L., Lee T., Fu J., Ritchie M.E. Characterization of MAP kinase and PKC isoform and effect of ACE inhibition in hypertrophy in vivo. Am. J. Physiol. 277:1999;H1808-H1816.
43. Sauro M.D., Fitzpatrick D.F. Atrial natriuretic peptides inhibit protein kinase C activation in rat aortic smooth muscle. Pept. Res. 3:1990;138-141.
44. Anand-Srivastava M.B., Sehl P.D., Lowe D.G. Cytoplasmic domain of natriuretic peptide receptor-C inhibits adenylyl cyclase. Involvement of a pertussis toxin-sensitive G protein. J. Biol. Chem. 271:1996;19324-19329.
45. Hirata M., Chang C.H., Murad F. Stimulatory effects of atrial natriuretic factor on phosphoinositide hydrolysis in cultured bovine aortic smooth muscle cells. Biochim. Biophys. Acta. 1010:1989;346-351.
46. Suga S., Nakao K., Hosoda K., et al. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology. 130:1992;229-239.
47. Gisbert M.P., Fischmeister R. Atrial natriuretic factor regulates the calcium current in frog isolated cardiac cells. Circ. Res. 62:1988;660-667.
48. Kourie J.I., Hanna E.A., Henry C.L. Properties and modulation of alpha human atrial natriuretic peptide (alpha-hANP)-formed ion channels. Can. J. Physiol. Pharmacol. 79:2001;654-664.
49. Wyatt T.A., Naftilan A.J., Francis S.H., Corbin J.D. ANF elicits phosphorylation of the cGMP phosphodiesterase in vascular smooth muscle cells. Am. J. Physiol. 274:1998;H448-H455.